Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

NVC

Neovasc Inc. (NVC)

Neovasc Inc.
일자:
정렬 기준:
 검색 관련기사 보기:TSXV:NVC
일자시간출처헤드라인심볼기업
2014/06/2020:00PR Newswire (Canada)Neovasc Inc. Announces Receipt of Final Approval to Graduate to the TSXTSXV:NVCNeovasc Inc.
2014/06/1920:00PR Newswire (Canada)Neovasc Inc. reports results of Annual General Meeting of ShareholdersTSXV:NVCNeovasc Inc.
2014/06/1303:18PR Newswire (Canada)Neovasc earns a spot in 2014 PROFIT 500 ListTSXV:NVCNeovasc Inc.
2014/06/0705:15PR Newswire (Canada)Neovasc Inc. provides initial comments on lawsuitTSXV:NVCNeovasc Inc.
2014/05/2220:00PR Newswire (Canada)Neovasc Inc. reports financial results for first quarter 2014TSXV:NVCNeovasc Inc.
2014/05/2123:45PR Newswire (Canada)Positive First-In-Human Experience With Neovasc's Tiara™ Transcatheter Mitral Valve Presented at EuroPCR 2014TSXV:NVCNeovasc Inc.
2014/05/1620:00PR Newswire (Canada)Neovasc Inc. to begin trading on the NASDAQ Capital MarketTSXV:NVCNeovasc Inc.
2014/05/1320:00PR Newswire (Canada)Neovasc Inc. Announces Upcoming Presentations at EuroPCR 2014TSXV:NVCNeovasc Inc.
2014/05/0820:00PR Newswire (Canada)Neovasc Hires Industry Veteran Vicki Bebeau as Vice President, Clinical AffairsTSXV:NVCNeovasc Inc.
2014/04/1807:17PR Newswire (Canada)Neovasc announces filing of shelf prospectus and application to list on NASDAQTSXV:NVCNeovasc Inc.
2014/04/1720:00PR Newswire (Canada)Neovasc Inc. Reports Financial Results For 2013TSXV:NVCNeovasc Inc.
2014/03/3120:00PR Newswire (Canada)COSIRA Study Data Presented at ACC.14 Confirms the Neovasc Reducer(TM) Improves Functional Capabilities in Refractory Angina ...TSXV:NVCNeovasc Inc.
2014/03/2622:24Marketwired CanadaNeovasc Inc. Closes C$25 Million Bought Deal Equity FinancingTSXV:NVCNeovasc Inc.
2014/03/1720:00PR Newswire (Canada)Neovasc Reducer™ for Refractory Angina Featured in Live Case Session at 10th Annual Congress of Update in Cardiology and Ca...TSXV:NVCNeovasc Inc.
2014/03/0421:00PR Newswire (Canada)Neovasc Inc. Provides Update on Tiara™ Transcatheter Mitral Valve and Reducer™ ProgramsTSXV:NVCNeovasc Inc.
2014/03/0405:42Marketwired CanadaNeovasc Announces C$25,152,000 Bought Deal Equity FinancingTSXV:NVCNeovasc Inc.
2014/02/0321:15PR Newswire (Canada)Neovasc Inc. Announces Successful First Human Implant of Tiara™ Transcatheter Mitral ValveTSXV:NVCNeovasc Inc.
2013/11/2021:28PR Newswire (Canada)Neovasc Inc. Reports Financial Results for Third Quarter of 2013TSXV:NVCNeovasc Inc.
2013/11/1321:28PR Newswire (Canada)Neovasc receives first US patent for its novel Tiara(TM) transcatheter mitral valve replacement technologyTSXV:NVCNeovasc Inc.
2013/11/0621:28PR Newswire (Canada)Neovasc Reducer™ Achieves Primary Endpoint in COSIRA Trial, Significantly Improving Functional Capabilities in Patients wit...TSXV:NVCNeovasc Inc.
2013/10/2920:28PR Newswire (Canada)Neovasc Inc. Announces Publication of Positive Tiara™ Preclinical Data in the Journal JACC: Cardiovascular InterventionsTSXV:NVCNeovasc Inc.
2013/10/2420:28PR Newswire (Canada)Neovasc Inc. announces upcoming presentations at TCT 2013 scientific symposiumTSXV:NVCNeovasc Inc.
2013/08/1520:28PR Newswire (Canada)Neovasc Inc. reports financial results for second quarter of 2013TSXV:NVCNeovasc Inc.
2013/05/2820:30PR Newswire (Canada)Neovasc Inc. Reports Financial Results for First Quarter of 2013TSXV:NVCNeovasc Inc.
2013/05/2320:30PR Newswire (Canada)Positive Animal Data Presented at EuroPCR Sets Stage for Advancing Neovasc's Tiara(TM) Transcatheter Mitral Valve into Human ...TSXV:NVCNeovasc Inc.
2013/05/2120:30PR Newswire (Canada)Registry Data Presented at EuroPCR 2013 Confirms the Neovasc Reducer™ Improves Cardiovascular Parameters in Refractory Angi...TSXV:NVCNeovasc Inc.
2013/05/1320:25PR Newswire (Canada)Neovasc Inc. Completes Enrollment in COSIRA Trial Assessing Efficacy of Reducer™ Product for Treatment of Refractory AnginaTSXV:NVCNeovasc Inc.
2013/04/2920:25PR Newswire (Canada)Neovasc Inc. reports financial results for 2012 year-endTSXV:NVCNeovasc Inc.
2013/04/2520:30PR Newswire (Canada)Neovasc Inc. reports exercise of 1.8 million warrants for net proceeds of $2.3 millionTSXV:NVCNeovasc Inc.
2013/02/2821:30PR Newswire (Canada)Neovasc's COSIRA clinical trial protocol selected for publication in peer-reviewed journalTSXV:NVCNeovasc Inc.
 검색 관련기사 보기:TSXV:NVC